NCT02415387View on ClinicalTrials.gov

Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

April 27, 2021

Study Completion Date

April 27, 2021

Conditions

Cognitive Side Effects of Cancer TherapyDepressionRecurrent Breast CarcinomaStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast Cancer

Interventions

BIOLOGICAL

typhoid vaccine

Given IM

OTHER

Placebo

Given IM

Trial Locations (1)

43210

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT02415387 - Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer | Biotech Hunter | Biotech Hunter